...
首页> 外文期刊>The Pediatric infectious disease journal >Mortality and Associated Factors After Initiation of Pediatric Antiretroviral Treatment in the Democratic Republic of the Congo.
【24h】

Mortality and Associated Factors After Initiation of Pediatric Antiretroviral Treatment in the Democratic Republic of the Congo.

机译:刚果民主共和国开始小儿抗逆转录病毒治疗后的死亡率和相关因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE:: We aimed to describe factors associated with mortality among children receiving antiretroviral treatment (ART) at a pediatric hospital in Kinshasa, Democratic Republic of the Congo. RESULTS:: Two hundred ninety-nine children, <18 years old, were followed for a median of 77 weeks (interquartile range: 61-103) post-ART initiation. Survival probability was 89.6% [95% confidence interval (CI): 85.5-92.6%] at 12 months; 24 of 31 deaths (77.4%) occurred within 2 months of ART initiation. Predictors of mortality in bivariate analysis were >/=2 opportunistic infections before ART initiation, severe immunosuppression as defined by age-specific CD4 count or percentage criteria, hemoglobin <9 g/dL, oral candidiasis, and severe malnutrition. In multivariate analysis, weight for age z-score [hazard ratio (HR): 0.39; 95% CI: 0.27-0.61; P < 0.001] and oral candidiasis (HR: 5.86; 95% CI: 2.34-14.65; P = 0.0002) were independent predictors of mortality. Suspected septic shock was the most common cause of death (n = 12/31, 38.7%). CONCLUSIONS:: Children receiving ART in this resource-poor setting were at the highest risk of dying in the first 2 months of ART, particularly when they presented with malnutrition or oral candidiasis. Optimal timing of ART initiation during nutritional rehabilitation should be determined. Promotion of early care seeking, strengthened health care, and prevention services are important to further improve outcome of pediatric ART in resource-poor settings.
机译:目的::我们旨在描述与在刚果民主共和国金沙萨一家儿科医院接受抗逆转录病毒治疗(ART)的儿童死亡率相关的因素。结果:接受ART治疗后的279名年龄<18岁的儿童的中位随访时间为77周(四分位范围:61-103)。 12个月生存率是89.6%[95%置信区间(CI):85.5-92.6%]; 31例死亡中有24例(77.4%)在抗病毒治疗开始后2个月内发生。在双变量分析中,死亡率的预测因素是ART开始前≥2的机会性感染,严重的免疫抑制(由年龄特异性CD4计数或百分比标准定义),血红蛋白<9 g / dL,口腔念珠菌病和严重营养不良。在多变量分析中,年龄z评分的权重[风险比(HR):0.39; 95%CI:0.27-0.61; P <0.001]和口腔念珠菌病(HR:5.86; 95%CI:2.34-14.65; P = 0.0002)是死亡率的独立预测因子。怀疑的败血性休克是最常见的死亡原因(n = 12 / 31,38.7%)。结论:在这种资源贫乏的环境中接受抗逆转录病毒治疗的儿童在抗逆转录病毒治疗的头2个月内死亡的风险最高,特别是当他们出现营养不良或口腔念珠菌病时。应确定营养康复期间抗病毒治疗的最佳时机。促进寻求早期护理,加强医疗保健和预防服务对于进一步改善资源贫乏地区的儿科抗逆转录病毒疗法的结果非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号